Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516341 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

2010 U.S. Type 2 Diabetes Patients’ Choice: Awareness, Usage, and Preferences of Insulin Injection Pens

Frost & Sullivan, March 2011, Pages: 63


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Type 2 diabetes is the most common form of diabetes. It is a chronic disease marked by high levels of glucose in the blood. Type 2 diabetes is most common in patients that are of 45 years or greater, have a high-density lipoprotein (HDL) cholesterol of less than 35 mg/dL or triglyceride level of greater than 250 mg/dL, and/or have high blood pressure. The primary goal to treat type 2 diabetes is diet and exercise. However, if diet and exercise does not help maintain normal glucose levels, physicians may prescribe medication

This Frost & Sullivan research service titled 2010 U.S. Type 2 Diabetes Patients’ Choice: Awareness, Usage, and Preferences of Insulin Injection Pens provides the findings of a Web-based survey conducted among 1,002 adult type 2 diabetic patients who use an injection pen to administer insulin into their bodies. In this research, Frost & Sullivan's expert analysts examine the following markets: prefilled insulin injection pens and durable insulin injection pens. In addition, this study also analyzes awareness of injection pen brands, measures current usage of injection pen brands, as well as importance of features/attributes.

Market Overview

Pre-filled Injection Pens Emerge as the Most Preferred Mode to Administer Insulin by Type 2 Diabetes Patients in the United States

On an average, type 2 diabetic patients aged above 40 have been using insulin for more than five years. Approximately one-third of patients report they have been using insulin once per day for more than five years. Very few patients use the injection pen four times a day. Type 2 diabetic patients who have been taking insulin for the past 1 or 2 years make up the largest proportion of patients who have used four or more different types of insulin injection pens. More than one-quarter of U.S. type 2 diabetic patients report that they currently use a Lantus SoloSTAR (Sanofi-Aventis) insulin injection pen. It is the most recalled injection pen brand, when asked unaided and aided. However, awareness of the surveyed injection pen brands was moderate to low.

Currently, most diabetic patients use a disposable prefilled injection pen, with the highest usage reported among female patients and those aged above 50. “It appears that the prefilled injection pen may be preferred as patients no longer need to worry about refilling it,” says Christina Alfaro, Research Associate with Frost & Sullivan’s Customer Research Team. “The prefilled injection pen is simply more convenient to use for most patients with busy lifestyles as this pen type comes pre-filled with insulin, and when the insulin cartridge or reservoir is empty, the entire unit is discarded.” Such convenience has unsurprisingly led to the majority of patients to use the injection pen to self-administer insulin once or twice a day. Only a small proportion of patients report that the insulin is administered by someone else in the household.

Most patients are satisfied with the NovoPen Junior, HumaPen Luxura, and Lantus SoloSTAR Pen because these brands are perceived to be easiest to self-administer. Not surprisingly, this is the most important reason for satisfaction with the brands. Type 2 diabetic patients report they are willing to switch to another injection pen brand to see if it works better than the one they presently use, to try a different kind of injection pen brand, or simply, if their current injection pen brand is to be discontinued. “Pen memory, easy push-button, and safety interlock mechanism are the top features most commonly recalled among current insulin injection pen users,” notes Alfaro. “Thus, these are top features that brands are expected to have to be most competitive to incite switching behavior or maintain loyal diabetic patient users.”

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

- Prefilled insulin injection pens
- Durable insulin injection pens


Product samples

A sample for this product is available. Please Login/Register to download this sample.

For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds